Lancet Gastroenterology and Hepatology
ISSN: 2468-1253
eISSN: 2468-1156
Publisher: Elsevier: Lancet
Publications (9)
Further efficacy and safety data for maintenance upadacitinib in ulcerative colitis (2023)
Atreya R, Neurath M
Journal article
Induction of microRNA-124 as a novel therapeutic concept in ulcerative colitis (2022)
Atreya R, Neurath M
Journal article
Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial (2022)
Sandborn WJ, Panés J, Danese S, Sharafali Z, Hassanali A, Jacob-Moffatt R, Eden C, et al.
Journal article
Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial (2020)
Atreya R, Peyrin-Biroulet L, Klymenko A, Augustyn M, Bakulin I, Slankamenac D, Miheller P, et al.
Journal article
Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial (2019)
Traussnigg S, Schattenberg JM, Demir M, Wiegand J, Geier A, Teuber G, Hofmann WP, et al.
Journal article
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study (2018)
Feagan BG, Panes J, Ferrante M, Kaser A, D'Haens GR, Sandborn WJ, Louis E, et al.
Journal article
Mechanisms of molecular resistance and predictors of response to biological therapy in inflammatory bowel disease (2018)
Atreya R, Neurath M
Journal article, Review article
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study (2017)
Jones D, Boudes PF, Swain MG, Bowlus CL, Galambos MR, Bacon BR, Doerffel Y, et al.
Journal article
Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study (2016)
Louvet A, Labreuche J, Moreno C, Vanlemmens C, Moirand R, Feray C, Dumortier J, et al.
Journal article